Get the Stockscreener App
21.79
7.39%
-1.74
After Hours:
22.01
0.22
+1.01%
Hims Hers Health Inc stock is traded at $21.79, with a volume of 18.28M.
It is down -7.39% in the last 24 hours and down -1.63% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
See More
Previous Close:
$23.53
Open:
$23.05
24h Volume:
18.28M
Relative Volume:
1.41
Market Cap:
$4.76B
Revenue:
$1.24B
Net Income/Loss:
$101.26M
P/E Ratio:
-128.18
EPS:
-0.17
Net Cash Flow:
$149.62M
1W Performance:
-21.05%
1M Performance:
-1.63%
6M Performance:
+17.15%
1Y Performance:
+181.52%
1-Day Range:
$21.44
$23.12
1-Week Range:
$19.15
$25.45
52-Week Range:
$7.505
$30.44
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| HIMS | 21.79 | 4.76B | 1.24B | 101.26M | 149.62M | -0.17 |
| PG | 170.89 | 401.37B | 83.91B | 14.32B | 15.85B | 6.16 |
| UL | 57.55 | 143.21B | 64.93B | 7.15B | 0 | 3.4285 |
| CL | 93.91 | 76.48B | 20.11B | 2.87B | 3.40B | 1.92 |
| KVUE | 23.78 | 45.59B | 15.46B | 1.06B | 1.40B | 0.496 |
| KMB | 136.37 | 45.48B | 20.10B | 2.61B | 2.90B | 5.20 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock? - AOL
Hims & Hers stock falls as Amazon launches Telehealth offering - MSN
Will Amazon Bury Hims Stock or Should You Buy the Dip? - Yahoo Finance
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead (NYSE:HIMS) - Seeking Alpha
TD Cowen reaffirms Buy rating on Hims and Hers stock, highlights FDA case impact - Investing.com
Connor Clark & Lunn Investment Management Ltd. Lowers Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Stock Gains 31.1% Since Q3 Earnings: What's Next? - MSN
Hims & Hers health chief commercial officer sells $165,000 in stock - Investing.com
hims & hers COO Melissa Baird sells shares worth $1.24 million - Investing.com
Hims & Hers Health (NYSE:HIMS) Shares Gap DownShould You Sell? - MarketBeat
Hims & Hers Health Inc (HIMS) Trading 8.64% Higher on Nov 19 - GuruFocus.com
Hims & Hers stock (HIMS) drops 24% after Amazon telehealth announcement—here's why - InvestorsObserver
Hims & Hers Stock Climbs After Former Regulator Autor Joins Board - Marketscreener.com
Unpacking the Latest Options Trading Trends in Hims & Hers Health - Benzinga
Hims & Hers Stock Tumbles Amid Amazon Telehealth Push - AskTraders
Price Over Earnings Overview: Hims & Hers Health - Benzinga
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions - BioSpace
Hims & Hers Bolsters Leadership with Former FDA Commissioner, Quality Expert | HIMS Stock News - StockTitan
Royce & Associates LP Increases Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Should You Buy Hims & Hers Stock On The Dip? - Barchart
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
Hims & Hers Stock Is Down 30% This Week: Here's What Happened - AOL
Insider Sale: Director David Wells Sells 40,000 Shares of Hims & Hers Health Inc (HIMS) - GuruFocus.com
Should You Buy Hims & Hers Stock on the Dip? - Nasdaq
Hims & Hers: Revolutionizing Telehealth And Captivating InvestorsHere's Why You Should Buy - Seeking Alpha
Hims & Hers Health: The Amazon Curse Is Being Overstated (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Insider Trades Send A Signal - Benzinga
Hims Drops Most Ever as Amazon Enters Hair-Loss Drug Market - The Business of Fashion
Hims & Hers Shares Drop Following Amazon's Expansion into Telehe - GuruFocus.com
Hims & Hers Shares Drop Following Amazon's Expansion into Telehealth - Yahoo Finance
State of New Jersey Common Pension Fund D Has $2.28 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Director Anja Manuel Acquires 5,000 Shares of Hims & Hers Health Inc (HIMS) - GuruFocus.com
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments - The Wall Street Journal
Hims & hers director Manuel Anja acquires $132,259 in stock - Investing.com
Hims & Hers health CFO sells shares worth $4.28 million - Investing.com
Hims & Hers director David Wells sells $1.2 million in stock - Investing.com
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare - MSN
Notable Thursday Option Activity: HIMS, PAG, SNOW - Nasdaq
BofA cuts Hims & Hers rating on Amazon market entry - Investing.com
BofA cuts Hims & Hers rating on Amazon market entry By Investing.com - Investing.com Australia
Hims & Hers Stock’s Retail Army Brushes Off Amazon Medical One’s Rival Service Even As Citi Sees Threat - MSN
Hims & Hers stock tanks as Amazon debuts fixed pricing for hair-loss and erectile-dysfunction drugs - Fast Company
Amazon to Sell Cheap Hair-Loss Drugs. It’s a Big Threat for Hims & Hers Stock. - Barron's
Hims & Hers cut to underperform by BoA over Amazon competition (NYSE:HIMS) - Seeking Alpha
Amazon launches lifestyle drug service as challenge to Hims & Hers - Yahoo Finance
Amazon's push into telehealth knocks shares of Hims & Hers - MSN
Amazon Challenges Telehealth With New Affordable Service - Finimize
What's Going On With Hims & Hers Health Stock On Wednesday? - AOL
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
2.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):